ZANIDATAMAB-HRII

82 reported adverse events

Drug classes: Bispecific HER2-directed Antibody [EPC]

These side effects are most commonly reported by patients taking ZANIDATAMAB-HRII:

# Side effect Count
0 OFF LABEL USE 23
1 INFUSION RELATED REACTION 11
2 DIARRHOEA 10
3 CHILLS 9
4 PYREXIA 6
5 EJECTION FRACTION DECREASED 4
6 HYPERPYREXIA 3
7 ACUTE KIDNEY INJURY 2
8 ARTHRALGIA 2
9 DISEASE PROGRESSION 2
See all common reactions for ZANIDATAMAB-HRII

ZANIDATAMAB-HRII is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HER2 POSITIVE GASTRIC CANCER 1 0.0312
1 PRODUCT IMPURITY 1 0.0036
2 HEPATIC INFECTION 1 0.0008
3 HYPERPYREXIA 3 0.0007
4 LIVER ABSCESS 1 0.0003
5 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
6 EJECTION FRACTION DECREASED 4 0.0003
7 RECURRENT CANCER 1 0.0002
8 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
9 STRESS CARDIOMYOPATHY 1 0.0002
See all enriched reactions for ZANIDATAMAB-HRII